Jonathan M. Behar et al. JACEP 2017;3:

Slides:



Advertisements
Similar presentations
Hazard of incident coronary heart disease by diabetes status, with or without elevation of troponin T No diabetes Pre- diabetes Diabetes No diabetes Pre-
Advertisements

Flow diagram of the systematic literature search indicating the inclusion and exclusion process of studies Liakopoulos OJ, et al. Eur Heart J 2008;29:
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence, Temporal Trends, and Prognostic Impact.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Habitual Coffee Consumption on Cardiometabolic.
From: Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction.
Introduction Out-of-hospital cardiac arrest (OHCA) is the sudden cessation of the heart in an out of hospital setting. In the United States, the incidence.
Figure e-1. Further Meta-analysis of previously reported PD and mtDNA haplogroup associations and the data from this study.   Meta-analysis of published.
Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype status. Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype.
Cardiac Resynchronization Therapy Using Quadripolar Versus Non‐Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single‐Site Left.
Cost Utility of Sirolimus versus Tacrolimus for the Primary Prevention of Graft Rejection in Renal Transplant Recipients in Mexico  Kely Rely, Rosa María.
Ahmed Abuzaid, MD, Carly Fabrizio, DO, Kevin Felpel, MD, Haitham S
F - Ratio Table Degrees of Freedom for the Factor
Bart S. Ferket, MD, PhD, Jonathan M
Noriko Kikuchi et al. JACEP 2016;2:
José L. Morales et al. JACEP 2017;j.jacep
Baseline characteristics of patients
Drug Rate ratio 95% CI Thiazide diuretics 1.0 Reference ACE inhibitors
Konstantinos C. Siontis et al. JACEP 2016;2:
Shadi Al Halabi et al. JACEP 2015;1:
Cost Utility of Sirolimus versus Tacrolimus for the Primary Prevention of Graft Rejection in Renal Transplant Recipients in Mexico  Kely Rely, Rosa María.
Ashish Shukla et al. JACEP 2015;1:41-51
Dileep Raman et al. JACEP 2017;3:
Angelo Auricchio, and Frits W. Prinzen JACEP 2017;3:
Wesley T. O’Neal et al. JACEP 2016;2:
Tornado diagram of the percentage change in the base case ICER from one-way sensitivity analyses of key input variables. Tornado diagram of the percentage.
Impact of Preoperative Angiotensin-Converting Enzyme Inhibitor Use on Clinical Outcomes After Cardiac Surgery  Maral Ouzounian, MD, Karen J. Buth, MS,
Figure 2 Absolute difference in seasonal peak
Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.
Elliott P, et al. JAMA 2009;302:37-48.
Volume 9, Issue 1, Pages (January 2012)
Imran Niazi et al. JACEP 2017;j.jacep
David J.A. Jenkins et al. JACC 2018;71:
Tornado diagram of one-way deterministic sensitivity analysis.
Jonathan M. Behar et al. JACEP 2017;j.jacep
Mintu P. Turakhia et al. JACEP 2016;2:
Konstantinos C. Siontis et al. JACEP 2016;2:
Angelo Auricchio, and Frits W. Prinzen JACEP 2017;j.jacep
Svend A. Mortensen et al. JCHF 2014;2:
Prabhat Kumar et al. JACEP 2016;j.jacep
Marwan Badri et al. JACEP 2015;1:
Anna Björkenheim et al. JACEP 2017;j.jacep
Mintu P. Turakhia et al. JACEP 2016;2:
Emilce Trucco et al. JACEP 2018;j.jacep
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Figure 1 Cumulative late adjusted survival in cardiac resynchronization therapy defibrillator and pacemaker patients. ... Figure 1 Cumulative late adjusted.
Maneesh Sud et al. JCHF 2017;5:
Ahmed Abuzaid, MD, Carly Fabrizio, DO, Kevin Felpel, MD, Haitham S
Anna Björkenheim et al. JACEP 2017;j.jacep
Forest plot of adjusted odds ratios (with 95% confidence intervals) from multivariable multinomial logistic regression analysis (table 4), by number of.
Jordan B. King et al. JCHF 2016;4:
T2DM patients with HF may benefit from SGLT2 inhibitor therapy
Adjusted relative risk Adjusted odds ratio
Associations between type of MI and incident HF
Saadia Sherazi et al. JACEP 2015;1:74-80
MRRs and EMRRs for women with ACS
Lifetime heart failure risk*
One-way sensitivity analysis.
Cost-effectiveness plane for all PARTNER-B vs all ADVANCE and all PARTNER vs ADVANCE high risk comparisons with ICERs from five studies; dashed line represents.
Pamela E. Scott et al. JACC 2018;71:
Jeffrey Senfield et al. JACEP 2017;3:
Increase of physical activity over time associated with lower HF risk
Forest plot of the association between early coronary angiography and survival in patients with out-of-hospital cardiac arrest A: including unadjusted.
Orly Vardeny et al. JCHF 2016;4:
Gianluigi Savarese et al. JCHF 2016;4:
Kaplan-Meier plot for the prespecified primary endpoint (CARE-HF (A) and the secondary composite endpoint (all-cause mortality and new onset heart failure.
Associations of dialysis session length with mortality and hospitalizations. Associations of dialysis session length with mortality and hospitalizations.
Conceptual framework of cost-effectiveness of recombinant tissue plasminogen activator (rtPA) therapy. Conceptual framework of cost-effectiveness of recombinant.
Summary of incremental cost-effectiveness ratio (ICERs) of rtPA therapy from the literature. Summary of incremental cost-effectiveness ratio (ICERs) of.
Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.
Tornado diagram of one-way sensitivity analyses on key model parameters. Tornado diagram of one-way sensitivity analyses on key model parameters. Parameters.
Presentation transcript:

Jonathan M. Behar et al. JACEP 2017;3:107-116 Tornado Plot Showing the Impact of Varying the Input Parameter Values to Their Upper and Lower 95% CIs on the Base-Case ICER Hatched bars show the impact of using the lower 95% confidence interval (CI); solid bars show the impact of using the upper 95% CI. Data labels on each bar show the incremental cost-effectiveness ratio (ICER) resulting from the change in value. A shift to the right of the center line shows an ICER that denotes less favorable cost-effectiveness than the base case. ACS = acute coronary syndrome; c = cost of; HF = heart failure; hosp = hospitalization; QALY = quality-adjusted life-year; quad = quadripolar cardiac resynchronization therapy system; u = utility value. Jonathan M. Behar et al. JACEP 2017;3:107-116 2017 The Authors